Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2-Reference-Cited by-同舟云学术

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2

Published:2018-07-15 Issue:3 Volume:50 Page:917-925
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Eoh Kyung Jin,Kim Ji Eun,Park Hyung Seok,Lee Seung-Tae,Park Ji Soo,Han Jung Woo,Lee Jung-Yun,Kim Sunghoon,Kim Sang Wun,Kim Jae Hoon,Kim Young Tae,Nam Eun Ji

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2017-220.pdf

Reference28 articles.

1. Meta-Analysis ofBRCA1andBRCA2Penetrance

2. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

3. Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

4. Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients

5. Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families;Journal of Personalized Medicine;2024-08-16

2. Germline Mutational Landscape and Novel Targetable RAD51D Variant in Chinese Patients With Ovarian Cancer;JCO Global Oncology;2024-06

3. Germline mutations of 4567 patients with hereditary breast-ovarian cancer spectrum in Thailand;npj Genomic Medicine;2024-02-14

4. Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation;Cold Spring Harbor Perspectives in Medicine;2023-12-27

5. Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?;International Journal of Molecular Sciences;2023-11-30